CZM has too much skin in the game, they can't afford to let OIL fail. Not with a current market cap at $27.59M. This link, reproduced below, from 23 March 2017:
"Carl Zeiss Meditec AG reported Tuesday that it has issued 8,130,960 new shares, a ten percent increase in share capital, in order to raise cash for acquisitions. The per share price was €38.94, resulting in a total increase of available cash reserves of €317 million. The shares were offered exclusively to institutional investors and will carry full dividend rights for the past fiscal year.
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec, said in the statement: “We are delighted with the very strong demand for our new shares. The realised proceeds will provide us with the necessary firepower and flexibility to selectively exploit opportunities in our markets and to sustainably accelerate our growth. We would like to thank our new and existing shareholders for the high level of trust.”
OIL Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)